TO THE EDITOR: In their article, Saitz and colleagues (1) conclude that the brief intervention is inadequate for medical inpatients with unhealthy alcohol use. We fear that their main finding is old wine in new skins: Brief intervention is ineffective in alcohol-dependent individuals.
TO THE EDITOR: Saitz and colleagues described null findings in their recent article on a brief intervention for medical inpatients with unhealthy alcohol use (1) . They concluded that the brief intervention "is inadequate" for these patients. We would like to suggest an alternative interpretation of their results.
The authors reported that fewer than 35% of eligible patients agreed to participate in their study. Thus, the sample may have been biased in that it probably comprised individuals who were amenable to discussing their alcohol consumption. Given that addiction is marked by denial and that problem recognition is typically viewed as a first step to recovery, it seems unlikely that this sample is representative of the population of alcohol-abusing hospital inpatients, many of whom reportedly do not view their drinking as problematic. Rather, the sample may have consisted primarily of individuals in the contemplation or preparation stages of change, meaning that they were already thinking about or were preparing to make a change in their drinking (although this information was not reported by the authors).
Assessment and feedback, as well as offering the patient assistance (if desired), are considered key components of brief motivational interventions. Thus, as Saitz and colleagues discussed, the extended assessment and feedback sessions that the control group received may have been an adequate intervention. This assumption is supported by the study finding that almost half of the control sample sought treatment for their alcohol addiction in the months after their hospitalization. The surprising nature of these results is highlighted by the authors' own a priori hypothesis that only 4% of the participants in the control group would seek help. Rather than viewing the brief intervention as "inadequate," perhaps it would be more appropriate to view the inpatient assessment and feedback as the single most effective brief intervention for patients who are already considering making a change. For some, it may be a tipping pointenough to tip the balance toward action.
It would be worthwhile to examine the effectiveness of the brief motivational intervention among patients in trauma and emergency departments and inpatients at addiction or psychiatric hospitals who are not interested in making a change (that is, individuals who are in the precontemplation stage). Brief motivational interventions are often successful in helping individuals move from precontemplation to contemplation or preparation, which may make these patients more receptive to offers of assistance.
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IN RESPONSE:
Drs. Bischof and Freyer-Adam did not correctly characterize the proportion of eligible participants who enrolled in our study. It was 65% (341 of 524 persons), which is remarkably high for an alcohol brief intervention trial. Readiness to change, AUDIT, and many other alcohol severity-related characteristics were similar in those enrolled, those eligible who did not enroll, and those with risky use who were ineligible (1).
Our trial had fewer exclusion criteria than most trials (2), and readiness was not among them. Nonetheless, many of our participants were considering change (as noted in Table 1 of our article). Furthermore, in medical patients, greater readiness is not predictive of less drinking or problems, calling into question approaches that select participants for intervention on the basis of stage of change (3, 4) . We find lack of representativeness an unlikely explanation for our findings.
Dr. Merlo and colleagues write that our control participants received "assessment and feedback sessions." However, control participants received no feedback. At least 3 reasons argue against assessment effects as an explanation for our results: 1) mixed-model analyses suggested a lack of effect (similar when including participants with 1 or 2 follow-up assessments), 2) evidence on assessment effects in this population (particularly in those not seeking treatment) is not yet sufficient, and 3) brief intervention studies in other settings have been positive despite assessments.
Brief intervention has efficacy in selected patients with nondependent, unhealthy alcohol use in primary care. In other settings (such as emergency departments and inpatient medicine services), brief interventions may not have efficacy-as trials are beginning to demonstrate. Moreover, evidence does not support efficacy in nontreatment-seeking adults with alcohol dependence. This is not old news in medical inpatients, and it is relevant now because brief intervention is currently being widely disseminated to these populations. We agree that brief intervention may have efficacy in nondependent inpatients, but this remains to be proven and will be relevant to only a small proportion of screen-positive inpatients (about 20%). Our study shows that most medical inpatients with unhealthy alcohol use identified by screening are unlikely to benefit from brief intervention alone, and it is not the first negative study in this setting (5) .
We do not agree that brief intervention is effective for inpatients who are considering change. Hospitalization may be a time for selfchange, but evidence that brief intervention improves on this is limited. Our study and others are the best approaches to providing evidence to direct clinical efforts and for how to improve care where current brief interventions fall short.
Adjusted-Dose Warfarin versus Aspirin for Preventing Stroke in Patients with Atrial Fibrillation
TO THE EDITOR: The recently published, randomized Birmingham Atrial Fibrillation Treatment of the Aged (BAFTA) Study compared adjusted-dose warfarin (target international normalized ratio, 2.0 to 3.0) with aspirin (75 mg/d) in 973 patients with atrial fibrillation who were 75 years of age or older (mean age, 81.5 years) and were managed by general practitioners in the United Kingdom (1). The study's important results indicate that the relative efficacy and safety of warfarin for stroke prevention can be extended to very elderly patients who are managed by nonspecialists. Because the BAFTA Study seems likely to be the last large trial comparing adjusted-dose warfarin with aspirin (and its results increase the total number of stroke events available for meta-analysis by 42%), we add the BAFTA results to our updated meta-analysis of antithrombotic trials in patients with atrial fibrillation (2) .
Including the BAFTA Study, 9 randomized trials enrolling 4620 participants compared adjusted-dose warfarin with aspirin. By meta-analysis, the relative risk reduction by warfarin over aspirin is 39% (95% CI, 19% to 53%) in these 8 predominantly primary prevention trials and single secondary prevention trial and remained at 39% when 3 comparisons of warfarin with nonaspirin antiplatelet agents were included (1) . The meta-analytic estimate for the absolute risk reduction by warfarin over aspirin for primary prevention is about 1% per year (Table) .
On the basis of all available randomized data, the relative risk reduction in all strokes by adjusted-dose warfarin versus antiplatelet therapy is about 40%. Despite some variations in results of earlier, smaller trials (Figure [1, 3-12 This concept is long overdue. It applies not just to procedural skills, but also to the recertification process-not just for internal medicine, but for family practice as well.
Why? It is almost a truism that the scope of knowledge and skills of practicing, nonacademic generalists, who have been in practice for many years, become narrowed because they limit their practices in some way. Either they use hospitalists for their hospital patients, or they don't feel comfortable treating certain diseases or because there are many specialists in the community who are better qualified.
The point is: Shouldn't the recertification process be tailored as well to reflect this? It seems senseless to test any kind of generalist on the same scope of knowledge he or she possessed when they finished their residencies. Too many physicians waste time and money taking board review examinations in family practice and general internal medicine, memorizing information that they will rarely or never use, just to pass a board examination. Not only is this an unnecessary burden, but it is way out of sync with reality. Most physicians subject themselves to the recertification process to defend against the possibility of being refused admission to a health maintenance organization panel or hospital staff. Neither are good reasons. Worse, some physicians feel that continuing medical education has become a cottage industry that is more intent on financial gain than anything else.
Furthermore, the recertification process should do away with the pass/fail mindset. Physicians already certified, and even those who are "board-eligible," should be given ongoing opportunities to improve themselves with knowledge tailored to their particular practices. One can argue that those who cram or take Board review courses actually prolong the inadequacy of the test.
The concept of tailoring to the needs of one's practice needs to be studied for its potential benefits.
